• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

鼻内咪达唑仑:两种给药装置在人类志愿者中的比较。

Intranasal midazolam: a comparison of two delivery devices in human volunteers.

作者信息

Dale Ola, Nilsen Turid, Loftsson Thorsteinn, Hjorth Tønnesen Hanne, Klepstad Pål, Kaasa Stein, Holand Trond, Djupesland Per G

机构信息

Pain and Palliation Research Group, Department of Circulation and Medical Imaging, Norwegian University of Science and Technology, 7489 Trondheim, Norway.

出版信息

J Pharm Pharmacol. 2006 Oct;58(10):1311-8. doi: 10.1211/jpp.58.10.0003.

DOI:10.1211/jpp.58.10.0003
PMID:17034653
Abstract

Bidirectional nasal drug delivery is a new administration principle with improved deposition pattern that may increase nasal drug uptake. Twelve healthy subjects were included in this open, non-randomized 3-way crossover study: midazolam (3.4 mg) intravenously (1 mg mL (-1)), or nasally by bidirectional or traditional spray (2 x100 microL of a 17 mg mL(-1) nasal midazolam formulation). The primary outcome was bioavailability. Blood samples were drawn for 6 h for determination (gas-chromatography-mass-spectrometry) of midazolam and 1-OH-midazolam. Pharmacokinetic calculations were based on non-compartmental modelling, sedation assessed by a subjective 0-10 NRS-scale, and nasal dimensions by non-invasive acoustic rhinometry. Mean bioavailabilities were 0.68-0.71, and Tmax 15 min for the sprays, which also were bioequivalent (ratio geometric means (90%) CI: 97.6% (90% CI 83.5; 113.9)). Sedation after bidirectional spray followed intravenous sedation closely, while sedation after the traditional spray was less pronounced. A negative correlation between Cmax and smallest cross-sectional area was seen. Adverse effects such as local irritation did not differ significantly between the sprays. Apparently bidirectional delivery did not increase systemic bioavailability of midazolam. We cannot disregard that only the traditional spray caused less sedation than intravenous administration. This finding needs to be confirmed in trials designed for this purpose.

摘要

双向鼻腔给药是一种新的给药原则,其沉积模式有所改善,可能会增加鼻腔药物吸收。12名健康受试者被纳入这项开放、非随机的三向交叉研究:静脉注射咪达唑仑(3.4mg,1mg/mL),或通过双向喷雾或传统喷雾鼻腔给药(2×100μL,17mg/mL的鼻腔咪达唑仑制剂)。主要结局是生物利用度。采集血样6小时,用于测定咪达唑仑和1-羟基咪达唑仑(气相色谱-质谱法)。药代动力学计算基于非房室模型,通过主观的0-10数字评定量表评估镇静情况,通过非侵入性鼻声反射法测量鼻腔尺寸。喷雾给药的平均生物利用度为0.68-0.71,达峰时间为15分钟,两者也具有生物等效性(几何均值比(90%)置信区间:97.6%(90%置信区间83.5;113.9))。双向喷雾后的镇静情况与静脉镇静密切相关,而传统喷雾后的镇静作用则较弱。观察到最大血药浓度与最小横截面积之间呈负相关。两种喷雾之间局部刺激等不良反应无显著差异。显然,双向给药并未增加咪达唑仑的全身生物利用度。我们不能忽视的是,只有传统喷雾引起的镇静作用比静脉给药弱。这一发现需要在为此目的设计的试验中得到证实。

相似文献

1
Intranasal midazolam: a comparison of two delivery devices in human volunteers.鼻内咪达唑仑:两种给药装置在人类志愿者中的比较。
J Pharm Pharmacol. 2006 Oct;58(10):1311-8. doi: 10.1211/jpp.58.10.0003.
2
Pharmacokinetics and pharmacodynamics of a new intranasal midazolam formulation in healthy volunteers.一种新型鼻内咪达唑仑制剂在健康志愿者中的药代动力学和药效学
Anesth Analg. 2006 Aug;103(2):344-9, table of contents. doi: 10.1213/01.ane.0000226150.90317.16.
3
Intranasal administration of midazolam in a cyclodextrin based formulation: bioavailability and clinical evaluation in humans.基于环糊精配方的咪达唑仑鼻内给药:人体生物利用度及临床评估
Pharmazie. 2001 Dec;56(12):963-6.
4
A pharmacokinetic and pharmacodynamic study, in healthy volunteers, of a rapidly absorbed intranasal midazolam formulation.一项针对快速吸收的鼻内咪达唑仑制剂在健康志愿者中的药代动力学和药效学研究。
Epilepsy Res. 2009 Feb;83(2-3):124-32. doi: 10.1016/j.eplepsyres.2008.10.005. Epub 2008 Nov 29.
5
A pharmacokinetic study of midazolam in dogs: nasal drop vs. atomizer administration.咪达唑仑在犬体内的药代动力学研究:滴鼻给药与雾化器给药对比
Pediatr Dent. 1998 Sep-Oct;20(5):321-6.
6
Intranasal administration of midazolam: pharmacokinetic and pharmacodynamic properties and sedative potential.咪达唑仑鼻腔给药:药代动力学和药效学特性及镇静潜力。
ASDC J Dent Child. 1997 Mar-Apr;64(2):89-98.
7
Effect of saquinavir on the pharmacokinetics and pharmacodynamics of oral and intravenous midazolam.沙奎那韦对口服及静脉注射咪达唑仑药代动力学和药效学的影响。
Clin Pharmacol Ther. 1999 Jul;66(1):33-9. doi: 10.1016/S0009-9236(99)70051-2.
8
Pharmacokinetics and pharmacodynamics of midazolam after intravenous and intramuscular administration in alpacas.在羊驼中静脉注射和肌肉注射咪达唑仑后的药代动力学和药效学
Am J Vet Res. 2013 Feb;74(2):294-9. doi: 10.2460/ajvr.74.2.294.
9
Abuse liability of intra-nasal midazolam in inhaled-cocaine abusers.吸入可卡因滥用者鼻内使用咪达唑仑的滥用可能性
Eur Neuropsychopharmacol. 2008 Oct;18(10):723-8. doi: 10.1016/j.euroneuro.2008.05.006. Epub 2008 Jul 14.
10
Pharmacokinetics, pharmacodynamics, and tolerability of USL261, midazolam nasal spray: Randomized study in healthy geriatric and non-geriatric adults.咪达唑仑鼻喷雾剂USL261的药代动力学、药效学及耐受性:健康老年和非老年成年人的随机研究
Epilepsy Behav. 2017 Jun;71(Pt A):51-59. doi: 10.1016/j.yebeh.2017.02.023. Epub 2017 May 23.

引用本文的文献

1
Clinical Pharmacokinetics and Pharmacodynamics of Naloxone.纳洛酮的临床药代动力学和药效学。
Clin Pharmacokinet. 2024 Apr;63(4):397-422. doi: 10.1007/s40262-024-01355-6. Epub 2024 Mar 14.
2
The Upper Nasal Space: Option for Systemic Drug Delivery, Mucosal Vaccines and "Nose-to-Brain".上鼻道:全身给药、黏膜疫苗及“鼻-脑通路”的选择
Pharmaceutics. 2023 Jun 13;15(6):1720. doi: 10.3390/pharmaceutics15061720.
3
Non-Invasive Strategies for Nose-to-Brain Drug Delivery.鼻脑给药的非侵入性策略
J Clin Trials. 2020;10(7). Epub 2020 Dec 10.
4
Safety and sedative effect of intranasal dexmedetomidine in mandibular third molar surgery: a systematic review and meta-analysis.鼻内注射右美托咪定在下颌第三磨牙手术中的安全性和镇静效果:一项系统评价和荟萃分析。
Drug Des Devel Ther. 2019 Apr 23;13:1301-1310. doi: 10.2147/DDDT.S194894. eCollection 2019.
5
Pharmacokinetics of a new, nasal formulation of naloxone.纳洛酮新鼻用制剂的药代动力学
Eur J Clin Pharmacol. 2017 May;73(5):555-562. doi: 10.1007/s00228-016-2191-1. Epub 2017 Jan 31.
6
Pharmacokinetics and pharmacodynamics of a new highly concentrated intranasal midazolam formulation for conscious sedation.一种用于清醒镇静的新型高浓度鼻内咪达唑仑制剂的药代动力学和药效学
Br J Clin Pharmacol. 2017 Apr;83(4):721-731. doi: 10.1111/bcp.13163. Epub 2016 Dec 20.
7
Low-dose oxytocin delivered intranasally with Breath Powered device affects social-cognitive behavior: a randomized four-way crossover trial with nasal cavity dimension assessment.使用呼吸动力装置经鼻给予低剂量催产素会影响社会认知行为:一项伴有鼻腔尺寸评估的随机四向交叉试验。
Transl Psychiatry. 2015 Jul 14;5(7):e602. doi: 10.1038/tp.2015.93.
8
Nasal drug delivery devices: characteristics and performance in a clinical perspective-a review.鼻腔给药装置:临床视角下的特点和性能——综述。
Drug Deliv Transl Res. 2013 Feb;3(1):42-62. doi: 10.1007/s13346-012-0108-9. Epub 2012 Oct 18.
9
Pharmacokinetics and pharmacodynamics of nasally delivered midazolam.经鼻给予咪达唑仑的药代动力学和药效学。
Br J Clin Pharmacol. 2010 Jun;69(6):607-16. doi: 10.1111/j.1365-2125.2010.03611.x.
10
Intranasal delivery of antiepileptic medications for treatment of seizures.用于治疗癫痫发作的抗癫痫药物的鼻内给药。
Neurotherapeutics. 2009 Apr;6(2):352-8. doi: 10.1016/j.nurt.2009.01.002.